Impact of pulmonary tuberculosis on COPD outcomes Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021
Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004
Assessment of COVID-19 impact on the course of pulmonary tuberculosis Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021
Effects of complex treatment with izofon of a pulmonary tuberculosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004
Characteristics and therapeutic outcomes of pulmonary tuberculosis in the elderly . Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017
Evaluating the nutritional status in active pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 427s Year: 2005
Aspects of diagnosis and treatment in pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 168s Year: 2002
Influence of pulmonary tuberculosis on the quality of life of the patients Source: Eur Respir J 2005; 26: Suppl. 49, 420s Year: 2005
Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
Economic impact of pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 472s Year: 2004
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Diagnosis and treatment delay in patients with pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003
Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004
Effect of pulmonary arterial hypertension on outcome of pulmonary tuberculosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis Source: Eur Respir J 2013; 41: 1393-1400 Year: 2013
The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Predictors of treatment outcome in multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011